These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10778588)

  • 1. Hypochromic anaemia in chronic renal failure--role of aluminium.
    Varma PP; Kumar R; Prasher PK; Roy ND
    J Assoc Physicians India; 1999 Jul; 47(7):690-3. PubMed ID: 10778588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicohaematological profile in chronic renal failure.
    Talwar VK; Gupta HL; Shashinarayan
    J Assoc Physicians India; 2002 Feb; 50():228-33. PubMed ID: 12038654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
    von Bonsdorff M; Sipilä R; Pitkänen E
    Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaemia, iron studies and erythropoietin in patients of chronic renal failure.
    Singh NP; Aggarwal L; Singh T; Anuradha S; Kohli R
    J Assoc Physicians India; 1999 Mar; 47(3):284-90. PubMed ID: 10999121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G; Gârneata L; Capusa C; Ursea N
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of iron deficiency to anemia in chronic renal failure.
    Gupta M; Kannan M; Gupta S; Saxena R
    Indian J Pathol Microbiol; 2003 Oct; 46(4):563-4. PubMed ID: 15025343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication.
    Short AI; Winney RJ; Robson JS
    Proc Eur Dial Transplant Assoc; 1980; 17():226-33. PubMed ID: 7243773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Helicobacter pylori does not contribute to iron deficiency in hemodialysis patients].
    López T; Almirall J; Calvet X; Quesada M; Sanfeliú I; Segura F; García M
    Nefrologia; 2006; 26(6):673-8. PubMed ID: 17227244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients.
    Schiffl H; Lang SM
    Nephrol Dial Transplant; 2006 Jan; 21(1):133-7. PubMed ID: 16144854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for the treatment of anemia in chronic renal failure].
    Triolo G;
    G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal evaluation of anaemic patients without evidence of iron deficiency.
    Powell N; McNair A
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1094-100. PubMed ID: 19047841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
    Tsuchiya K; Saito M; Okano-Sugiyama H; Nihei H; Ando M; Teramura M; Iwamoto YS; Shimada K; Akiba T
    Ren Fail; 2005; 27(1):59-65. PubMed ID: 15717636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM; Allen KR; Newton KE
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies.
    Touam M; Martinez F; Lacour B; Bourdon R; Zingraff J; Di Giulio S; Drüeke T
    Clin Nephrol; 1983 Jun; 19(6):295-8. PubMed ID: 6872366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic yield of routine duodenal biopsies in iron deficiency anaemia: a study from Western Anatolia.
    Gonen C; Yilmaz N; Yalcin M; Simsek I; Gonen O
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):37-41. PubMed ID: 17206075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.